180 related articles for article (PubMed ID: 32990984)
1. A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice.
Palmieri M; Kim HN; Gomez-Acevedo H; Que X; Tsimikas S; Jilka RL; Manolagas SC; Witztum JL; Ambrogini E
J Bone Miner Res; 2021 Jan; 36(1):170-185. PubMed ID: 32990984
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass.
Palmieri M; Joseph TE; O'Brien CA; Gomez-Acevedo H; Manolagas SC; Ambrogini E
PLoS One; 2022; 17(3):e0265893. PubMed ID: 35349600
[TBL] [Abstract][Full Text] [Related]
3. Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice.
Que X; Hung MY; Yeang C; Gonen A; Prohaska TA; Sun X; Diehl C; Määttä A; Gaddis DE; Bowden K; Pattison J; MacDonald JG; Ylä-Herttuala S; Mellon PL; Hedrick CC; Ley K; Miller YI; Glass CK; Peterson KL; Binder CJ; Tsimikas S; Witztum JL
Nature; 2018 Jun; 558(7709):301-306. PubMed ID: 29875409
[TBL] [Abstract][Full Text] [Related]
4. Neutralization of oxidized phospholipids attenuates age-associated bone loss in mice.
Palmieri M; Almeida M; Nookaew I; Gomez-Acevedo H; Joseph TE; Que X; Tsimikas S; Sun X; Manolagas SC; Witztum JL; Ambrogini E
Aging Cell; 2021 Aug; 20(8):e13442. PubMed ID: 34278710
[TBL] [Abstract][Full Text] [Related]
5. Oxidation-specific epitopes restrain bone formation.
Ambrogini E; Que X; Wang S; Yamaguchi F; Weinstein RS; Tsimikas S; Manolagas SC; Witztum JL; Jilka RL
Nat Commun; 2018 Jun; 9(1):2193. PubMed ID: 29875355
[TBL] [Abstract][Full Text] [Related]
6. Reduction of myocardial ischaemia-reperfusion injury by inactivating oxidized phospholipids.
Yeang C; Hasanally D; Que X; Hung MY; Stamenkovic A; Chan D; Chaudhary R; Margulets V; Edel AL; Hoshijima M; Gu Y; Bradford W; Dalton N; Miu P; Cheung DY; Jassal DS; Pierce GN; Peterson KL; Kirshenbaum LA; Witztum JL; Tsimikas S; Ravandi A
Cardiovasc Res; 2019 Jan; 115(1):179-189. PubMed ID: 29850765
[TBL] [Abstract][Full Text] [Related]
7. Oxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency.
Dou H; Kotini A; Liu W; Fidler T; Endo-Umeda K; Sun X; Olszewska M; Xiao T; Abramowicz S; Yalcinkaya M; Hardaway B; Tsimikas S; Que X; Bick A; Emdin C; Natarajan P; Papapetrou EP; Witztum JL; Wang N; Tall AR
Circulation; 2021 Dec; 144(24):1940-1954. PubMed ID: 34846914
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
[TBL] [Abstract][Full Text] [Related]
9. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG;
Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(A) with An Intact Lysine Binding Site Protects the Retina From an Age-Related Macular Degeneration Phenotype in Mice (An American Ophthalmological Society Thesis).
Handa JT; Tagami M; Ebrahimi K; Leibundgut G; Janiak A; Witztum JL; Tsimikas S
Trans Am Ophthalmol Soc; 2015; 113():T5. PubMed ID: 26538774
[TBL] [Abstract][Full Text] [Related]
11. Novel Autoimmune IgM Antibody Attenuates Atherosclerosis in IgM Deficient Low-Fat Diet-Fed, but Not Western Diet-Fed
Cherepanova OA; Srikakulapu P; Greene ES; Chaklader M; Haskins RM; McCanna ME; Bandyopadhyay S; Ban B; Leitinger N; McNamara CA; Owens GK
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):206-219. PubMed ID: 31645128
[TBL] [Abstract][Full Text] [Related]
12. Novel immune assay for quantification of plasma protective capacity against oxidized phospholipids.
Bochkov V; Schoenenberger AW; Oskolkova O; Toth U; Stöckl J; Majdic O; Daci A; Resink TJ; Erne P; Philippova M
Biomark Med; 2016 Aug; 10(8):797-810. PubMed ID: 27416002
[TBL] [Abstract][Full Text] [Related]
13. The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity.
Tsimikas S; Witztum JL
Curr Opin Lipidol; 2008 Aug; 19(4):369-77. PubMed ID: 18607184
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression.
Tsimikas S; Aikawa M; Miller FJ; Miller ER; Torzewski M; Lentz SR; Bergmark C; Heistad DD; Libby P; Witztum JL
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):175-81. PubMed ID: 17082490
[TBL] [Abstract][Full Text] [Related]
15. Targeting oxidized phospholipids by AAV-based gene therapy in mice with established hepatic steatosis prevents progression to fibrosis.
Upchurch CM; Yeudall S; Pavelec CM; Merk D; Greulich J; Manjegowda M; Raghavan SS; Bochkis IM; Scott MM; Perez-Reyes E; Leitinger N
Sci Adv; 2022 Jul; 8(28):eabn0050. PubMed ID: 35857497
[TBL] [Abstract][Full Text] [Related]
16. The high-density lipoprotein receptor Scarb1 is required for normal bone differentiation in vivo and in vitro.
Tourkova IL; Dobrowolski SF; Secunda C; Zaidi M; Papadimitriou-Olivgeri I; Papachristou DJ; Blair HC
Lab Invest; 2019 Dec; 99(12):1850-1860. PubMed ID: 31467425
[TBL] [Abstract][Full Text] [Related]
17. RETRACTED: Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass.
Palmieri M; Joseph TE; O'Brien CA; Gomez-Acevedo H; Kim HN; Manolagas SC; Ambrogini E
Bone; 2023 May; 170():116702. PubMed ID: 36773885
[TBL] [Abstract][Full Text] [Related]
18. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
Tsimikas S; Bergmark C; Beyer RW; Patel R; Pattison J; Miller E; Juliano J; Witztum JL
J Am Coll Cardiol; 2003 Feb; 41(3):360-70. PubMed ID: 12575961
[TBL] [Abstract][Full Text] [Related]
19. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
[TBL] [Abstract][Full Text] [Related]
20. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.
Bossola M; Tazza L; Luciani G; Tortorelli A; Tsimikas S
J Nephrol; 2011; 24(5):581-8. PubMed ID: 21404224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
